Form 4: Procter & Gamble Executive Moses Victor Javier Aguilar Reports Changes in Beneficial Ownership
SEC Form 4
Chief Research, Development & Innovation Officer of Procter & Gamble, Moses Victor Javier Aguilar, reports transactions involving common stock and restricted stock units.
Summary
- On August 5, 2024, Moses Victor Javier Aguilar, Chief Research, Development & Innovation Officer of Procter & Gamble, filed a Form 4 detailing changes in beneficial ownership.
- The transactions include acquisitions of restricted stock units and adjustments to holdings in retirement plans.
- Aguilar directly owns 13,009.7381 shares of common stock and indirectly owns 6,117.2612 shares through a retirement plan trustee and 428.6033 shares through an international stock ownership plan (Mexico) trustee.
- He also holds 53.6735 Series A Preferred Stock indirectly through a retirement plan trustee.
- Additionally, Aguilar acquired 552 restricted stock units on August 1, 2024, as a retirement award.
Sentiment
Score: 5
Explanation: This is a routine filing reflecting changes in beneficial ownership, with no inherently positive or negative implications.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their holdings in the company.
Key Dates
| Date | Description |
|---|---|
| 05/21/2004 | 2-for-1 stock split effective date |
| 06/30/2024 | Plan year end date for retirement award calculation |
| 07/16/2024 | Adjustment to PST through this date |
| 08/01/2024 | Transaction date for acquisition of restricted stock units |
| 08/05/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.